97 related articles for article (PubMed ID: 28787333)
1. Thromboembolisms in Advanced Pancreatic Cancer: A Retrospective Analysis of 475 Patients.
Ishigaki K; Nakai Y; Isayama H; Saito K; Hamada T; Takahara N; Mizuno S; Mohri D; Kogure H; Matsubara S; Yamamoto N; Tada M; Koike K
Pancreas; 2017 Sep; 46(8):1069-1075. PubMed ID: 28787333
[TBL] [Abstract][Full Text] [Related]
2. Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group.
Starling N; Rao S; Cunningham D; Iveson T; Nicolson M; Coxon F; Middleton G; Daniel F; Oates J; Norman AR
J Clin Oncol; 2009 Aug; 27(23):3786-93. PubMed ID: 19398575
[TBL] [Abstract][Full Text] [Related]
3. Incidence of cancer-associated thromboembolism in Japanese gastric and colorectal cancer patients receiving chemotherapy: a single-institutional retrospective cohort analysis (Sapporo CAT study).
Aonuma AO; Nakamura M; Sakamaki K; Murai T; Matsuda C; Itaya K; Sone T; Yagisawa M; Koike Y; Endo A; Tsukuda Y; Ono Y; Nagasaka A; Nishikawa S; Yamanaka T; Sakamoto N
BMJ Open; 2019 Aug; 9(8):e028563. PubMed ID: 31439602
[TBL] [Abstract][Full Text] [Related]
4. Analysis of incidence and clinical outcomes in patients with thromboembolic events and invasive exocrine pancreatic cancer.
Epstein AS; Soff GA; Capanu M; Crosbie C; Shah MA; Kelsen DP; Denton B; Gardos S; O'Reilly EM
Cancer; 2012 Jun; 118(12):3053-61. PubMed ID: 21989534
[TBL] [Abstract][Full Text] [Related]
5. Risks and impacts of thromboembolism in patients with pancreatic cancer.
Chan LL; Lam KY; Lam DCM; Lau YM; Li L; Ng KKC; Tang RSY; Chan SL
Hong Kong Med J; 2023 Oct; 29(5):396-403. PubMed ID: 37789507
[TBL] [Abstract][Full Text] [Related]
6. ABO non-O type as a risk factor for thrombosis in patients with pancreatic cancer.
Li D; Pise MN; Overman MJ; Liu C; Tang H; Vadhan-Raj S; Abbruzzese JL
Cancer Med; 2015 Nov; 4(11):1651-8. PubMed ID: 26275671
[TBL] [Abstract][Full Text] [Related]
7. Thromboembolism Incidence and Risk Factors in Multiple Myeloma After First Exposure to Immunomodulatory Drug-Based Regimens.
Patel JN; Robinson M; Jagosky M; Slaughter D; Arnall J; Jandrisevits E; Matusz-Fisher A; Atrash S; Paul B; Bhutani M; Voorhees P; Usmani SZ
Clin Lymphoma Myeloma Leuk; 2021 Mar; 21(3):188-198.e2. PubMed ID: 33339769
[TBL] [Abstract][Full Text] [Related]
8. Retrospective evaluation of thromboembolic events in patients with non-small cell lung cancer treated with platinum-based chemotherapy.
Mellema WW; van der Hoek D; Postmus PE; Smit EF
Lung Cancer; 2014 Oct; 86(1):73-7. PubMed ID: 25129368
[TBL] [Abstract][Full Text] [Related]
9. Symptomatic and incidental thromboembolism are both associated with mortality in pancreatic cancer.
Menapace LA; Peterson DR; Berry A; Sousou T; Khorana AA
Thromb Haemost; 2011 Aug; 106(2):371-8. PubMed ID: 21713322
[TBL] [Abstract][Full Text] [Related]
10. Arterial and venous thromboembolic events during anti-TNF therapy: a study of 85 spontaneous reports in the period 2000-2006.
Petitpain N; Gambier N; Wahl D; Chary-Valckenaere I; Loeuille D; Gillet P;
Biomed Mater Eng; 2009; 19(4-5):355-64. PubMed ID: 20042802
[TBL] [Abstract][Full Text] [Related]
11. Thromboembolic events in patients with urothelial carcinoma undergoing neoadjuvant chemotherapy and radical cystectomy.
Zareba P; Patterson L; Pandya R; Margel D; Hotte SJ; Mukherjee SD; Elavathil L; Daya D; Shayegan B; Pinthus JH
Urol Oncol; 2014 Oct; 32(7):975-80. PubMed ID: 25027682
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and co-morbidities in adolescent thromboembolism are different than those in younger children.
Ishola T; Kirk SE; Guffey D; Voigt K; Shah MD; Srivaths L
Thromb Res; 2016 May; 141():178-82. PubMed ID: 27060749
[TBL] [Abstract][Full Text] [Related]
13. Demographic characteristics, thromboembolism risk, and treatment patterns for patients with cold agglutinin disease in Japan.
Kamesaki T; Nishimura JI; Wada H; Yu E; Tsao E; Morales J; Kanakura Y
Int J Hematol; 2020 Sep; 112(3):307-315. PubMed ID: 32608010
[TBL] [Abstract][Full Text] [Related]
14. Postoperative early thromboembolism as a prognostic indicator in patients with curatively resected pancreatic cancer.
Hwang IK; Kang BK; Lee YS; Cho JY; Yoon YS; Hwang JH; Han HS; Kim J
Am J Surg; 2015 Nov; 210(5):871-7. PubMed ID: 26002191
[TBL] [Abstract][Full Text] [Related]
15. Impact of Nab-Paclitaxel-based Second-line Chemotherapy in Metastatic Pancreatic Cancer.
Dadi N; Stanley M; Shahda S; O'Neil BH; Sehdev A
Anticancer Res; 2017 Oct; 37(10):5533-5539. PubMed ID: 28982867
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic head carcinoma: clinical analysis of 189 cases.
Hua YP; Liang LJ; Peng BG; Li SQ; Huang JF
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):79-84. PubMed ID: 19208521
[TBL] [Abstract][Full Text] [Related]
17. Thromboembolism Incidence and Risk Factors in Children with Cancer: A Population-Based Cohort Study.
Pelland-Marcotte MC; Pole JD; Kulkarni K; Athale U; Stammers D; Sabapathy C; Halparin J; Brandão LR; Sung L
Thromb Haemost; 2018 Sep; 118(9):1646-1655. PubMed ID: 30103249
[TBL] [Abstract][Full Text] [Related]
18. A varying-coefficient cox model for the effect of CA19-9 kinetics on overall survival in patients with advanced pancreatic cancer.
Chen Y; Shao Z; Chen W; Xie H; Wu Z; Qin G; Zhao N
Oncotarget; 2017 May; 8(18):29925-29934. PubMed ID: 28404893
[TBL] [Abstract][Full Text] [Related]
19. Impact of Different Treatment Modalities on the Outcome of Pancreatic Cancer.
Khan M; Ashraf MI; Syed AA; Hanif F
J Coll Physicians Surg Pak; 2017 Aug; 27(8):470-474. PubMed ID: 28903837
[TBL] [Abstract][Full Text] [Related]
20. Competing Risks for Mortality in Patients With Asymptomatic Pancreatic Cystic Neoplasms: Implications for Clinical Management.
Kwok K; Chang J; Duan L; Huang BZ; Wu BU
Am J Gastroenterol; 2017 Aug; 112(8):1330-1336. PubMed ID: 28534524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
